News: $RGRX RegeneRx and Lee's Pharm to Accelerate RGN-259 Development in China
ROCKVILLE, Md. and HONG KONG , March 26, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, and Lee's Pharmaceutical Holdings Limited ...